Emtricitabine

Composition

The formulation contains Emtricitabine 200 mg with microcrystalline cellulose, sodium starch glycolate, magnesium stearate, and gelatin as the active ingredient.

Indications

Indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents.

Side effects

Common side effects include headache, diarrhea, nausea, fatigue, and skin discoloration.

Precautions

Monitor liver function, renal function, and signs of lactic acidosis; use with caution in patients with renal impairment or hepatic disease; avoid concurrent use with other nephrotoxic drugs.

Contraindications

Known hypersensitivity to emtricitabine or its components

Dosage and administration

200 mg once daily, with or without food

Countries

USA, South Africa, India

Available Forms

Capsules, oral solution

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai